Discovery of JNJ-42847922, a selective orexin-2 antagonist for the treatment of insomnia disorder

被引:0
|
作者
Letavic, Michael [1 ]
Bonaventure, Pascal [1 ]
Ly, Kiev [1 ]
Aguilar, Zuleima [2 ]
Aluisio, Leah [1 ]
Carruthers, Nicholas [1 ]
Chaplan, Sandra [2 ]
Dugovic, Christine [1 ]
Halter, Robin [2 ]
Koudriakova, Tatiana [2 ]
Lord, Brian [1 ]
Lovenberg, Timothy [1 ]
Kramer, Michelle [2 ]
Morton, Kirsten [1 ]
Ndifor, Anthony [2 ]
Rizzolio, Michele [2 ]
Shah, Chandra [2 ]
Shelton, Jonathan [1 ]
Shoblock, James [1 ]
Sutton, Steven [1 ]
机构
[1] Janssen Pharmaceut Co, Neurosci Drug Discovery, San Diego, CA USA
[2] Janssen Pharmaceut Co, San Diego, CA USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
244
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Discovery of MK-6096: A novel dual orexin receptor antagonist for the treatment of insomnia
    Coleman, Paul J.
    Schreier, John D.
    Cox, Christopher D.
    Breslin, Michael J.
    Whitman, David B.
    McGaughey, Georgia B.
    Bednar, Rodney A.
    Lemaire, Wei
    Doran, Scott M.
    Fox, Steve V.
    Garson, Susan L.
    Gotter, Anthony L.
    Harrell, C. Meacham
    Reiss, Duane R.
    Stevens, Joanne
    Tannenbaum, Pamela L.
    Prueksaritanont, Thomayant
    Cabalu, Tamara D.
    Cui, Donghui
    Ball, Richard G.
    Stellabott, Joyce
    Hartman, George D.
    Winrow, Christopher J.
    Renger, John J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [22] Discovery and early development of MK-1064: A potent, orally bioavailable, selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
    Roecker, Anthony J.
    Mercer, Swati P.
    Cox, Christopher D.
    Fraley, Mark E.
    Schreier, John D.
    Steen, Justin T.
    Tannenbaum, Pamela L.
    Gotter, Anthony L.
    Garson, Susan L.
    Fox, Steven V.
    Harrell, C. Meacham
    Stevens, Joanne
    Lemaire, Wei
    Bruno, Joseph G.
    Stellabott, Joyce
    Higgins, John D.
    Cabalu, Tamara D.
    Cui, Dan
    Prueksaritanont, Thomayant
    Hartman, George D.
    Young, Steven D.
    Winrow, Christopher J.
    Renger, John J.
    Forman, Mark S.
    Coleman, Paul J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [23] Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists
    Fujimoto, Tatsuhiko
    Kunitomo, Jun
    Tomata, Yoshihide
    Nishiyama, Keiji
    Nakashima, Masato
    Hirozane, Mariko
    Yoshikubo, Shin-ichi
    Hirai, Keisuke
    Marui, Shogo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6414 - 6416
  • [24] Almorexant, a dual orexin receptor antagonist for the treatment of insomnia
    Neubauer, David N.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (01) : 101 - 110
  • [25] Lemborexant Dual orexin receptor antagonist Treatment of insomnia
    Hoyer, D.
    Jacobson, L. H.
    DRUGS OF THE FUTURE, 2018, 43 (10) : 715 - 730
  • [26] Intracerebroventricular injection of orexin-2 receptor antagonist promotes REM sleep
    Kummangal, Basheer Ahamad
    Kumar, Deependra
    Mallick, Hruda Nanda
    BEHAVIOURAL BRAIN RESEARCH, 2013, 237 : 59 - 62
  • [27] DARIDOREXANT: A DUAL, EQUIPOTENT, AND INSURMOUNTABLE ANTAGONIST OF BOTH OREXIN-1 AND OREXIN-2 RECEPTORS
    Grandjean, Celia Mueller
    Kiry, Manon
    Vaillant, Catherine
    Nayler, Oliver
    Gatfield, John
    SLEEP, 2021, 44 : A25 - A25
  • [28] The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia
    Brooks, Sander
    Jacobs, Gabriel E.
    de Boer, Peter
    Kent, Justine M.
    Van Nueten, Luc
    van Amerongen, Guido
    Zuiker, Rob
    Kezic, Iva
    Luthringer, Remy
    van der Ark, Peter
    van Gerven, Joop M. A.
    Drevets, Wayne
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (02) : 202 - 209
  • [29] Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
    Dauvilliers, Yves
    Zammit, Gary
    Fietze, Ingo
    Mayleben, David
    Seboek Kinter, Dalma
    Pain, Scott
    Hedner, Jan
    ANNALS OF NEUROLOGY, 2020, 87 (03) : 347 - 356
  • [30] Sleep-inducing effects mediated by a selective orexin-2 receptor antagonist during the light phase in the rat
    Shelton, J.
    Sutton, S.
    Yun, S.
    Li, S.
    Dvorak, C.
    Carruthers, N.
    Lovenberg, T.
    Dugovic, C.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 : 201 - 201